Bendamustine Accord 2.5 mg/ml inj. sol. (pwdr., conc.) i.v. vial

Country: Բելգիա

language: անգլերեն

source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

active_ingredient:

Bendamustine Hydrochloride 25 mg

MAH:

Accord Healthcare B.V.

ATC_code:

L01AA09

INN:

Bendamustine Hydrochloride

dosage:

2,5 mg/ml

pharmaceutical_form:

Powder for concentrate for solution for infusion

composition:

Bendamustine Hydrochloride 25 mg

administration_route:

Intravenous use

therapeutic_area:

Bendamustine

leaflet_short:

CTI code: 484915-03 - Pack size: 20 x 25 mg - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 484915-02 - Pack size: 10 x 25 mg - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 484915-01 - Pack size: 5 x 25 mg - Commercialisation status: YES - FMD code: 05055565750032 - CNK code: 3397098 - Delivery mode: Medical prescription

authorization_status:

Commercialised: Yes

authorization_date:

2015-12-17